Washington, June 11 (ANI): Researchers have developed a veritable "time bomb", a nanocontainer, which can increase the effectiveness of treatments against cardiovascular disease and reduce side effects.
Read more:
Inter American University of Puerto Rico Chooses Nanoprofessor as Foundation for New Nanoscience Education Program
SKOKIE, IL--(Marketwire -06/11/12)- NanoProfessor, a division of NanoInk, Inc. focused on nanotechnology education, announced today that Inter American University of Puerto Rico in Bayamn has chosen the NanoProfessor Nanoscience Education Program to serve as the foundation for its new nanoscience education program. The Bayamn campus will become the first location in Puerto Rico to implement the NanoProfessor Program.
Inter American University has partnered with NanoProfessor through a grant award from the U.S. Department of Education's Minority Science and Engineering Improvement Program (MSEIP) to promote long-range improvement in science and engineering education at predominantly minority institutions. The NanoProfessor Program fits well into the goals of the grant, as it aims to expand hands-on nanotechnology education from the cleanrooms of research-based universities to undergraduate classrooms, such as those at Inter American University of Puerto Rico.
"We are pleased that Inter American University of Puerto Rico has chosen the NanoProfessor Nanoscience Education Program as the foundation for its new nanotechnology curriculum," said Dean Hart, chief commercial officer of NanoInk. "Aside from tourism, important industries within Puerto Rico's economy include pharmaceuticals, electronics, renewable energy, and aerospace; and nanotechnology is yielding breakthroughs in all of these areas. Students who complete the NanoProfessor Program at the Bayamn campus of Inter American University of Puerto Rico will help meet the nano-savvy workforce needs of these growing and high paying industries."
"Through the NanoProfessor Program, our students will gain hands-on experience and training with state-of-the-art instrumentation used by professionals in the nanotechnology field today," said Dr. Nedim Vardar, School of Engineering of Inter American University. "We are committed to providing our students with a meaningful education and the cutting-edge skills needed to help them land jobs and build careers in growth industries, such as those using nanotechnology to revolutionize their businesses and products."
Nanotechnology is the understanding and control of matter at dimensions between approximately one and 100 nanometers (nm), where unique phenomena enable novel applications which are not feasible when working with bulk materials. A nanometer is one-billionth of a meter. Encompassing nanoscale science, engineering, and technology, nanotechnology involves imaging, measuring, modeling, and manipulating matter at the nanoscale. A study funded by the National Science Foundation projects that six million nanotechnology workers will be needed worldwide by 2020, with two million of those jobs in the United States. However, as of 2008, there were only 400,000 estimated workers worldwide in the field of nanotechnology, with an estimated 150,000 of those in the United States.
The NanoProfessor Nanoscience Education Program alternates between classroom lectures and hands-on lab work. The curriculum includes a textbook authored by leading nanotechnology experts, covering the topics of Nanotechnology Basics, Nanophysics, Nanochemistry, Nanobiology, and Environmental, Health, and Safety perspectives on nanotechnology. In conducting the hands-on lab experiments, students learn the fundamentals for building custom-engineered nanoscale structures while working with state-of-the-art equipment including NanoInk's NLP 2000 Desktop NanoFabrication System, a student-friendly atomic force microscope (AFM), a best-of-class fluorescence microscope, an advanced nanoparticle characterization instrument, and various chemical and biological materials used today within current and emerging nanotechnology applications.
Inter American University of Puerto Rico (IAUPR) is a private, Hispanic Serving Higher Education non-profit institution founded in 1912, with eleven academic units throughout the Island. The Bayamn campus of Inter American University of Puerto Rico (IAUPRBC) is a specialized academic unit with emphasis on technology, engineering, aviation, computing, communications, science, and business administration. More information is available at http://bayamon.inter.edu.
About the NanoProfessor Nanoscience Education Program The NanoProfessor Nanoscience Education Program aims to advance undergraduate nanotechnology education and address the growing need for a skilled, nano-savvy workforce. The NanoProfessor Program, including instruments, an expert-driven curriculum, and student/teacher support materials, is available for high schools, community colleges, technical institutes, and universities worldwide. More information is available at http://www.NanoProfessor.net or (847)679-NANO (6266). You can also like NanoProfessor on Facebook at http://www.facebook.com/NanoProfessor1 and follow on Twitter at http://www.twitter.com/nanoprofessor1.
NanoInk, NanoProfessor, and the NanoProfessor logo, are trademarks or registered trademarks of NanoInk, Inc.
Read more here:
Molecular Imaging Informs Kidney Cancer Treatment
ImmunoSPECT imaging shows that the effectiveness of a newly developed radioimmunotherapy for treating a resistant form of kidney cancer could be diminished when used after another anti-cancer therapy.
Go here to read the rest:
PET imaging could lead to better care for neuroendocrine cancer
Public release date: 11-Jun-2012 [ | E-mail | Share ]
Contact: Susan Martonik smartonik@snm.org 703-652-6773 Society of Nuclear Medicine
Miami Beach, Fla. (June 11, 2012)A method of molecular imaging that pinpoints hormonally active tissues in the body could change the course of treatment for a remarkable number of neuroendocrine cancer patients, say researchers at the Society of Nuclear Medicine's 59th Annual Meeting.
An investigation of a molecular imaging method used to evaluate neuroendocrine patients prior to treatment was found to change management in more than 35 percent of the patients following imaging.
Patients who were previously considered inoperable went on to have surgery, and patients with previously unknown and extensive cancer who were originally slated for surgery were considered inoperable. Ruling out surgery in cases that are unlikely to be treated successfully with resection saves patients from the stress and potential complications of unnecessary surgeries.
"The study shows that this particular molecular imaging technique does significantly change patient management, identifying operable and curable symptomatic patients or sparing patients from futile surgery," says Niklaus Schaefer, M.D., lead investigator at the University Hospital of Zurich in Zurich, Switzerland. "The positive impact on our patients is also significant. This serves as a model for further use of molecular imaging to assess neuroendocrine tumors."
Neuroendocrine tumors originate from cells of the neuroendocrine system, which regulates the effect of hormones in various organs throughout the body where hormones are active. This is especially the case in the lungs and gastrointestinal tract, where the rates of respiration and digestion are moderated by hormones. Many of these cancers are asymptomatic and metastatic, which means they can develop unnoticed and spread from their original location to other tissues and organs. Clinical decision-making can be a challenge when determining the most appropriate treatment for patients with these cancers.
In this study, investigators were looking at a molecular imaging method that combines positron emission tomography (PET), which provides information about physiological processes in the body, and computed tomography (CT), ideal for imaging structure. PET/CT was performed in conjunction with injection of an imaging probe that works by combining the radionuclide Gallium-68 (Ga-68) with a molecular compound that mimics hormones called somatostatins that regulate the neuroendocrine system. Upon injection, the probe begins interacting with neuroendocrine cellsespecially those within cancerous tumors, because they are more active than healthy cells. These biological processes show up as "hot-spots" on PET scans, letting clinicians know where neuroendocrine cancer is proliferating.
Results of the study indicated that PET/CT and Ga-68 DOTATATE was highly sensitive and specific for assessing neuroendocrine tumors and changed the course of treatment for a large number of patients. Prior to imaging, more than half of the 61 patients who were picked for the study were considered eligible for surgery to remove their cancer. The remaining 29 were determined to be inoperable. Subjects were then imaged using Gallium-68 DOTATATE PET/CT. After molecular imaging, about 36 percent of patients had a change in their management. Of those who were originally classified as operable, 14 were subsequently considered ineligible for surgery. For patients who were at first considered inoperable, 8 patients went on to have surgical resection of their tumors.
"This is the first prospective trial investigating the role of Gallium-68 DOTATATE in a multidisciplinary clinical setting and its impact on further patient management," says Schaefer. "Molecular imaging with this biomarker is already available in several centers around the world, and expansion of its use has the potential to help these patients and their treating physicians, who can use it to set up a clinical plan in one single investigation."
Read more here:
PET imaging could lead to better care for neuroendocrine cancer
Molecular imaging finds link between low dopamine levels and aggression
ScienceDaily (June 11, 2012) Out of control competitive aggression could be a result of a lagging neurotransmitter called dopamine, say researchers presenting a study at the Society of Nuclear Medicine's 2012 Annual Meeting. During a computer game against a putative cheating adversary, participants who had a lower capacity to synthesize this neurotransmitter in the brain were more distracted from their basic motivation to earn money and were more likely to act out with aggression.
For many people, anger is an almost automatic response to life's challenges. In clinical psychiatry, scientists look at not only the impact of aggressive behavior on the individual, their loved ones and the community but also the triggers in the brain that lead to aggressive response. The neurobiology of aggression is not well understood, but scientists are aware of a relationship between the neurotransmitter serotonin and certain aggressive behaviors. The objective of this study was to explore whether higher levels of another brain chemical called dopamine, involved in pleasure and reward, increased aggressive response in its subjects. To scientists' surprise, it was not as they first theorized.
"The results of this study were astonishingly opposite of what was previously hypothesized," says Ingo Vernaleken, M.D., lead author of the study and research scientist for the department of psychiatry at RWTH Aachen University in Aachen, Germany. "Subjects with more functional dopaminergic reward-systems were not more aggressive in competitive situations and could concentrate even more on the game. Subjects with lower dopaminergic capacity were more likely to be distracted by the cheating behavior."
In this study, 18 healthy adults in their twenties were tested for aggression using the psychological behavioral task known as the point subtraction aggression paradigm (PSAP). Participants were asked to play a computer game that required them to press a bar multiple times with the incentive of winning money, but they were also told that an adversary in the next room who is able to cheat may steal some of their winnings. What the paranoid participants did not know was that there was no adversary. The computer program is designed to perform randomized deductions of the subjects' monetary reward to simulate the cheating competitor.The participant had three choices to react: punish the cheater, shield against the adversary by repeatedly pressing a defense button, or continue playing the game in order to maximize their ability to win cash, which indicated resilience.
"The PSAP focuses on aggressive reaction within a competitive situation," says Vernaleken. "Aggression and its neurobiological mechanisms in humans have been only moderately investigated in the past. Furthermore, most of the previous studies mainly covered the more reactive part of aggression, which merely reflects impulsive behavior and appears to be associated merely with the serotonin system. This investigation focuses on the association with the dopaminergic reward-system, which reflects goal-directed aggression."
Subjects' brains were imaged using positron emission tomography, which provides a range of information about physiological functions inside the body, depending on the imaging probe used. In this investigation, F-18 FDOPA, a biomarker that lights up enzymes' ability to synthesize this transmitter, was used and the uptake of this drug in the brain was analyzed to gauge the correlation between the participants' dopamine synthesis capacity and aggressive behavior.
Results of the study showed a significant impact on aggressive response in areas in the brain where dopamine synthesis was present, especially in the basal ganglia, which among other functions include the motivation center. Minimized aggression was associated with higher dopamine levels in both the midbrain and the striatum, which plays a role in planning and executive function. People with greater capacity for dopamine synthesis were more invested in the monetary reward aspect of the PSAP, instead of acting in defense or with aggression against their perceived adversary, whereas subjects with lower capacities had a higher vulnerability to act either aggressive, defensive or both.
"Thus, we think that a well-functioning reward system causes more resilience against provocation," says Vernaleken. "However, we cannot exclude that in a situation where the subject would directly profit from aggressive behavior, in absence of alternatives, the correlation might be the other way around."
Further research is required to explore the link between dopamine and a range of aggressive behavior. More insight into these relationships could potentially lead to new psychological therapies and drug treatments to moderate or prevent aggressive response.
Share this story on Facebook, Twitter, and Google:
Continue reading here:
Molecular imaging finds link between low dopamine levels and aggression
Molecular imaging 'sees' inside coronary arteries to measure disease
Public release date: 11-Jun-2012 [ | E-mail | Share ]
Contact: Susan Martonik smartonik@snm.org 703-652-6773 Society of Nuclear Medicine
Miami Beach, Fla. (June 11, 2012)Patients with cardiovascular disease will now benefit from a powerful new molecular imaging tool to detect disease in the main arteries supplying oxygen to the heart, say researchers presenting studies at the Society of Nuclear Medicine's 2012 Annual Meeting.
When an active heart needs more oxygen, blood vessels have a natural ability to open more so that greater amounts of blood can flow. The maximum dilation possible is the coronary flow reserve or CFR. This is an important reference, because it is one of the earliest signs of coronary artery disease, which is caused by atherosclerosis, a narrowing or hardening of these arteries due to a build-up of cholesterol and scar tissue. Diseased coronary arteries are unable to dilate as fully as healthy blood vessels, potentially limiting oxygen supply to the heart muscle.
The World Health Organization considers cardiovascular disease the number one cause of death and disability across the globe. Coronary artery disease is just one of a range of these diseases that can cause serious problems, including heart attack, if left untreated.
In two studies presented at the meeting, investigators examined quantitative imaging data to determine the true extent of coronary artery disease. In one study, researchers tested a molecular imaging method called myocardial perfusion imaging, also known as a stress test, conducted with positron emission tomography (PET). They then measured the CFR and calculated the precise dilation of blood vessels at rest and under stress. The objective of the study was to compare this technique's ability to predict arterial disease to a more conventional imaging method called angiography. In the other study, researchers used a PET stress test and measured CFR to determine whether age is always a risk factor for arterial disease.
"The quantification of CFR with molecular imaging provides a substantial advantage for unmasking coronary artery disease, even in patients who would otherwise be considered healthy with normal myocardial perfusion imaging," says Michael Fiechter, M.D., lead investigator of one study in cardiac imaging at the department of radiology for University Hospital Zurich, Zurich, Switzerland.
Measuring CFR goes beyond traditional myocardial perfusion imaging, which is based on visual interpretation of the differences between blood flow at rest and under stress, and instead actually quantifies coronary artery disease using imaging data acquired during scanning. The molecular imaging technique is made possible with PET, which uses injected imaging probes that emit signals picked up by a specialized scanner. Coronary artery disease is often evaluated using angiography, an X-ray procedure that involves catheterization and the injection of a dye into the coronary arteries in order to image blood flow and structure of the vessels, and echocardiography, which uses sound waves to image the heart.
"Although different studies revealed a prognostic value of CFR, this study is the first that systematically assessed the diagnostic value of CFR against invasive coronary angiography as a standard of reference for detection of coronary artery disease," says Philipp Kaufmann, M.D., a lead author of one of the studies in the department of radiology and cardiac imaging at University Hospital Zurich, Zurich, Switzerland.
In the two presented studies, a total of 777 elderly participants underwent myocardial perfusion imaging with PET and either Rb-82 or N-13-ammonia as an imaging biomarker to evaluate quantitative CFR as an indicator for coronary artery disease. One study of 73 participants concluded significant improvements across five different reference points including sensitivity, positive predictive value, and accuracy of myocardial perfusion imaging compared to imaging studies without CFR measurements.
Here is the original post:
Molecular imaging 'sees' inside coronary arteries to measure disease
Molecular imaging detects signs of Alzheimer's in healthy patients
Public release date: 11-Jun-2012 [ | E-mail | Share ]
Contact: Susan Martonik smartonik@snm.org 703-652-6773 Society of Nuclear Medicine
Miami Beach, Fla. (June 11, 2012)An arsenal of Alzheimer's research revealed at the Society of Nuclear Medicine's 59th Annual Meeting indicates that beta-amyloid plaque in the brain not only is involved in the pathology of Alzheimer's disease but may also precede even mild cognitive decline. These and other studies advance molecular imaging for the early detection of beta-amyloid, for which one product is now approved in the United States , as a major push forward in the race for better treatments.
"Diagnosis of Alzheimer's disease can now be made when the patient first presents symptoms and still has largely preserved mental function," says Christopher Rowe, M.D., a lead investigator for the Australian Imaging, Biomarkers and Lifestyle study of aging (AIBL) and professor of nuclear medicine at Austin Hospital in Melbourne, Australia. "Previously there was an average delay of three years between consulting a doctor over memory concerns and the diagnosis of Alzheimer's, as the diagnosis required the presence of dementia. When used as an adjunct to other diagnostic measures, molecular imaging can help lead to earlier diagnosis. This may give the patient several years to prepare for dementia while they still have control over their destiny."
According to the World Health Organization, Alzheimer's disease affects an estimated 18 million people worldwide, and incidence of the disease is expected to double by the year 2025 to 34 million. The National Institute on Aging estimates that as many as 50 percent of Americans aged 85 or older are affected.
Alzheimer's disease is a chronic and currently incurable neurodegenerative disease. Beta-amyloid burden can begin to build in the brain several years, if not more than a decade, before an individual shows any sign of dementia. Those who go on to develop Alzheimer's disease not only lose their ability to remember their loved ones but also have difficulty with essential bodily functions such as breathing and swallowing in the late stages of disease.
In one study, researchers used a molecular imaging technique called positron emission tomography (PET), which images physiological patterns in the body. PET was combined with an imaging agent called F-18 florbetaben, which binds to amyloid in the brain. This and other PET agents are drawn to targets in the body and emit a positron signal that is picked up by a scanner. Here molecular imaging was performed in conjunction with clinical and neuropsychological testing in order to better understand the long-term effects of beta amyloid plaques in the brains of older individuals with mild cognitive impairment. Those of the 45 subjects in the study who showed high levels of imaging agent binding during imaging and atrophy of the hippocampus, the memory center, had an 80 percent chance of developing Alzheimer's disease within two years, researchers said.
"Molecular imaging is proving to be an essential part of Alzheimer's disease detection," says Rowe. "This and other amyloid imaging techniques will have an increasing role in the earlier and more accurate diagnosis of neurodegenerative conditions such as Alzheimer's disease due to their ability to measure the actual underlying disease process."
Another AIBL study included 194 healthy participants, 92 people with mild cognitive impairment and 70 subjects with Alzheimer's disease, and used another imaging agent called C-11 PiB (Pittsburgh compound B) with PET to gauge amyloid burden in the brain. Researchers showed that, in this study group, widespread amyloid plaque build-up preceded cognitive impairment, and those with extensive amyloid burden were at higher risk of cognitive decline.
This and another study mark two of the first studies of their kind focusing on beta amyloid in healthy subjects. In the other study, 137 adults with normal cognitive function aged 30 to 89 years were imaged using PET with F-18 florbetapir, now FDA-approved for the detection of beta amyloid plaques, as well as functional magnetic resonance imaging in order to explore how amyloid build-up affects connections in specific areas of the brain involved in cognition, namely the default mode and salience networks, which are responsible for different states of wakeful rest and alertness. Those with increased amyloid burden in these neural networks were prone to impaired cognitive performance.
Read this article:
Molecular imaging detects signs of Alzheimer's in healthy patients
UPDATE VIDEO – Less Uploads :) – Video
10-06-2012 14:15 FOLLOW ME LADS FOR BANTER Allright Lads 🙂 hope you dont mind that there is 1 upload every 2 days and sometimes only 3 or 4 week 🙂 I will make them good for you thats why! need time for ideas!
Read more here:
FR-1X Leon’s Evaluation – Part 1 – Video
10-06-2012 18:07 Rosy's Music Store: This video is the first in a series that I will upload to demonstrate the new Roland FR-1X accordion with the beginning accordionist in mind. I will be uploading them individually as I complete them.
See original here:
Hypnosis – Suggestibility Tests : #1 Magnetic and Stuck Hands ( Re-Upload ) – Video
11-06-2012 03:19 This is a re upload of the same video And this will not work for all of you i want you to comment and tell me if it works or not or suggestions of my next videos tags (ignore) "Hypnosis (Literature Subject)" "Hand (Art Subject)" Control Mind "Art (Type Of Museum)" Your Youtube Brain Hands Mp4 Keep Body Put Hold Player Out Remote Upload Won Holding Power Media Reason Mpeg Sequence Avi H264 "Get Smart (TV Program)" Improved Sharing Audio Clap "Your Hands" Streaming "Put Your" Format Down Mpeg2 Dvd Export Converter Ntsc Public magnet funny webcam lol good music mp3 mpeg avi re upload amazing modder 360 xbox mw2 games mod Hack Combat Hacks Arms "Combat Arms" Bug Mods Induction Rapid Instant Arm Drop 8 word
See the rest here:
Hypnosis - Suggestibility Tests : #1 Magnetic and Stuck Hands ( Re-Upload ) - Video
Hypnosis – Suggestibility Tests : #2 Thumbs Stuck Together ( Re-Upload ) – Video
11-06-2012 03:34 This is my second video of Suggestibility tests This one is called thumbs stuck together This will not work for all of you But comment and tell me the result and new suggestions for my further videos Tags ( Ignore ) "Hypnosis (Literature Subject)" Control Mind Youtube "Literature (Literary School Or Movement)" Brain Mp4 Body Player Upload Out Remote Power Media Mpeg Reason Sequence Avi H264 Improved Sharing Pinky Audio Human Streaming Format Tricks Mpeg2 "Out Control" Jedi Dvd Export Lose Master Parts "Remote Control" Thoughts Converter Experiment Ntsc Ultra Share Widescreen Copy Alex Using Mpeg4 Lan Rapid Instant Induction Universal Memory "New Improved" Record 800kbps 640x480 Quicktime Default
View original post here:
Hypnosis - Suggestibility Tests : #2 Thumbs Stuck Together ( Re-Upload ) - Video
She Doesn’t Mind – Video
Facebook Rolls Out New Photo Layouts
Facebook is the worlds largest photo-sharing site, and its not even close. Every single day, users upload 250 million photos. Seriously, pause and think about that number for bit. Now imagine how many photos are uploaded in a weeka montha year? It is estimated that Facebook actually houses somewhere around 4% of all photos ever taken in the history of the world.
With billions upon billions of photos, its no surprise that Facebook is focusing on that aspect of its users experience. It has been argued that the photo-sharing sphere is the ultimate future of the social network, and growth and user engagement is directly tied to maintaing dominance as the worlds premier place to look at pictures. A recent billion dollar acquisition should tell you that.
With all of that in mind, Facebook is beginning to upgrade the desktop News Feed to make photo-browsing more interesting. Last week, we told you that Facebook was starting to roll out new photo layouts to its users. The new layouts mimicked the ones that users have seen on Facebooks iOS and Android apps bigger photos and more photos displayed in posts.
For instance, heres the large photo flanked by three smaller photo look that has appeared on mobile for a few weeks as it currently appears on the web version:
And thats not the only one. Some users have begun to see a bunch of new layouts including a four-panel one and a nine-panel one.
Heres what the four-panel layout looks like:
And heres the nine-panel layout:
Excerpt from:
Medicine – Video
Penn Medicine Cardiologist Chairs National Report on Optimal Use of Vascular Laboratory Tests for Patients with Known …
PHILADELPHIA A new report issued today by the American College of Cardiology (ACC) and developed in collaboration with 10 other leading professional societies provides detailed criteria to help clinicians maximize the appropriate use of certain noninvasive vascular tests when caring for patients with suspected or known non-coronary arterial disorders. Emile R. Mohler, MD, professor of Medicine and director of Vascular Medicine at Penn Medicine, chaired the national committee producing the criteria.
"This is the first systematic and comprehensive evaluation looking at appropriate indications for vascular testing, such as ultrasound or functional testing," said Dr. Mohler, who is also a member of the Penn Medicine Cardiovascular Institute. "We hope this document will help clinicians determine whether or not and when to refer individual patients for testing."
Ultrasound and other noninvasive laboratory tests can be essential tools to help clinicians evaluate vascular blockages and disease, for example, in the arteries of the neck, kidneys, abdomen, and lower extremities, as well as the aorta itself. Such testing also plays a central role in surveillance of the vascular system in some patients to help inform treatment decisions and prevent serious problems, and is part of follow-up after peripheral vascular procedures, such as arterial bypass, surgical removal of plaque (endarterectomy), or stenting. Still, guidance about when and how to best use this technology in practice is largely missing, according to experts.
Such decisions affect a growing number of patients as the population ages. Dr. Mohler estimates more than 20 million adults in the U.S. have some form of vascular disease, and would likely be a candidate for these types of tests.
The panel identified common clinical scenarios when noninvasive vascular testing might be considered in patients with suspected or known non-coronary arterial disorders (e.g., narrowing or blockages in the arteries of the neck, kidneys, abdomen or legs, abdominal aortic aneurysms, arterial dissection). Applying a rigorous rating scale, the 19-member panel then assessed the appropriateness of each indication and often at different time intervals (3-5, 6-8 and 9-12 months).
In addition to looking at the reasons for ordering these tests, the work group also sought to determine how frequently repeat testing is needed in clinical practice in light of the need for ongoing surveillance in some patients.
The appropriate use criteria were developed in collaboration with the ACC, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Laboratories, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society of Interventional Radiology, Society for Vascular Medicine and Society for Vascular Surgery. The document is further endorsed by the American Academy of Neurology, American Podiatric Medical Association, Society for Clinical Vascular Surgery, Society for Cardiovascular Magnetic Resonance, and Society for Vascular Ultrasound.
For more information on the new guidelines, please see the ACC press release.
The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Here is the original post:
Geomagic Demonstrates How Medicine Meets 3D at OMTEC 2012 Event
MORRISVILLE, N.C.--(BUSINESS WIRE)--
Geomagic, a global company providing 3D technology solutions for digital reality, today announced it will showcase best practices and output from its customers digital orthopedic product workflows at this weeks OMTEC 2012 event in Chicago beginning Wednesday, June 13th. As orthopedic implant manufacturers work to apply the latest technologies to their patient-specific implant processes, Geomagics customers demonstrate the results that are made possible when medicine meets 3D capture, touch-enabled design, 3D inspection and digital manufacturing technology.
Speakers and exhibits at OMTEC 2012 will depict the use of Geomagics products in the latest materials for the ultimate in personalized fit, form and function. For example, Level 3 Inspections Bill Greene will outline the advantages of Computer Aided Inspection for orthopedic implants as a way to deliver better patient-specific forms, faster, with fewer iterations, less waste, and lower cost. Bill will be presenting at the conference on Thursday June 14, at 10 am CT.
Geomagic will be demonstrating its Freeform Modeling System for organic design and preparing files for manufacturing. Level 3 Inspection also will join Geomagic and demonstrate its scanning solution using Geomagic Qualify for inspection and analysis.
Advanced software is allowing us to solve clinical problems we couldnt even begin to touch before, and Geomagics solutions are at the heart of the innovation, said Barry Fell, president of Thermoplastic Products Corp. in Hummelstown PA, who designs and prototypes custom orthopedic implants.
By using Geomagics suite of 3D solutions, including Geomagic Studio to capture real world data, Freeform to develop designs, and Geomagic Qualify to inspect and check manufactured products, medical manufacturers are moving to successful mass custom manufacturing through 3D digital reality. Innovative orthopedic products created using Freeform, Geomagic Studio and Geomagic Qualify on display at OMTEC include:
Digital reality, like the digital economy, is a fact of life today, allowing art and science, and in this case medicine, to achieve breakthrough results that are not possible without our technology, said Ping Fu, CEO of Geomagic. A good example is the use of additive manufacturing in exciting new ways. What was previously utilitarian, and perhaps cast or vacuum formed with standard parts, now can be designed more elegantly, ergonomically and aesthetically and printed in new bio-compatible materials. Its a new era for the practitioners and patients in the orthopedic industry.
Geomagic is exhibiting in booths 831-833 at OMTEC, which takes place at the Donald E. Stephens Convention Center, 5555 North River Road in Chicago, on Wednesday June 13 from 9 am 6 pm CT, and Thursday June 14 from 9 am 12 noon CT.
About Geomagic
Geomagic (www.geomagic.com) is a global company dedicated to advancing and applying 3D technology for the benefit of humanity. Different from CAD, Geomagic offers specific products to create 3D content from imaging the real world and real people, verify dimensional quality by comparing a master design to as-built products, and simulate touch sensations in digital environments. Products include Geomagic Studio, Geomagic Qualify, Geomagic customers are the most innovative companies in industries ranging from aerospace, automotive, toys, moldmaking, medical device, surgical simulation, consumer products, arts, heritage, research and education. Some of the leading companies around the globe using Geomagic products include Ford, BMW, Boeing, Harley Davidson, Timberland, Fisher Price, Lego, Pratt & Whitney, NASA, Schneider Electronic, 3M, Danaher and Invisalign. Geomagic is based in Research Triangle Park, NC, USA, with an office in Boston and subsidiaries in Europe and Asia, and channel partners worldwide.
See the original post:
Geomagic Demonstrates How Medicine Meets 3D at OMTEC 2012 Event
Medicine Dispensing Systems, a Subsidiary of Medbox, Inc., Emerges as a Leader in Arizona Medical Marijuana Clinic …
HOLLYWOOD, Calif., June 11, 2012 /PRNewswire/ -- Medicine Dispensing Systems, Inc., a subsidiary of Medbox, Inc., (MDBX) (www.medboxinc.com) has successfully completed and filed 110 applications for the granting of medical marijuana dispensing licenses for its consulting clients in the State of Arizona. The company completed the lengthy and complicated process on behalf of groups and individuals that are seeking to open dispensaries in Arizona's tightly regulated market.
Neither Medicine Dispensing Systems nor Medbox, Inc. own any marijuana dispensing clinics. The company acts as a consultant and helps guide those wishing to open a clinic through the complex issues that regulate the medical marijuana industry, and the steps that are necessary to operate in full compliance of each individual States regulations. The company has become nationally recognized as a leader in obtaining positive outcomes in the application process due to their comprehensive suite of services, which includes in-depth consultations, securing special zoning permits, handling lease negotiations, and specifying specialized clinic equipment.
The company also provides their patented Medbox Dispensing System, which is the most secure and transparent method to assure patient verification and compliance with all state and local regulations. The system, whether by machine or the company's POS system, is currently in use by over 100 clinics nationwide, and provides assurance to state regulators that clinics are being operated legitimately, legally, and in accordance with all rules governing these types of clinics.
Arizona voters approved a Measure in 2010 that allows certain qualifying patients to obtain medical marijuana from a registered dispensary. The Arizona Department of Health Services accepted dispensary applications from May 14 thru May 25, 2012.
The DHS received 484 dispensary applications for 126 possible dispensaries. The state allows a maximum of one dispensary per each of the State's 126 Community Health Analysis Areas (CHAAs). Arizona, with its forward-thinking regulations and seed to sale transparent tracking is looking to be the gold standard for future States as they navigate ways to allow their citizens access to medical marijuana without creating a detriment to the community. According to Will Humble, Arizona's Department of Health Services Director, the DHS expects to award the Dispensary Certificates on August 7.
"Our company is focused on States that have polished regulations concerning medical marijuana. States like Arizona and now Connecticut are setting a proper example for other States moving forward that have learned a lesson from less organized States like California and Colorado. The numbers of medical marijuana clinics should be based on population density and awarded by the State, in a tightly regulated system," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "Policies need to be crafted on a State level at the onset in order for these clinics not to cause a nuisance on communities."
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.
Read more here:
Shire's Advanced BioHealing Commits to Developing Regenerative Medicine Campus in San Diego
SAN DIEGO, June 11, 2012 /PRNewswire/ --
Shire plc, the global specialty biopharmaceutical company, announced today that its Regenerative Medicine business, Advanced BioHealing, Inc., has entered into a lease agreement with BioMed Realty Trust, Inc. which will allow the company to further expand its operational footprint and presence in the San Diego area over the next several years.
The new campus will provide Shire's Regenerative Medicine business the increased capacity it needs to meet future demand for its lead product, DERMAGRAFT, while offering additional space and infrastructure to manufacture new regenerative medicine products, in alignment with the business' strategic growth plan.
"We are committed to investing in and expanding our Regenerative Medicine business and with the signing of this lease, we are pleased to confirm and build our presence in San Diego with BioMed Realty as our real estate partner," said Kevin Rakin, Shire's Regenerative Medicine President. "This new campus will give us the flexibility and increased capacity we need to develop and manufacture new regenerative medicine therapies and build our foundation for continued growth in this exciting field."
Phase I of the site development will be in excess of 150,000 square feet and will house the company's manufacturing and associated support operations, commercial operations, corporate, and administrative functions. This expansion could create several hundred local jobs once the regenerative medicine campus is operational.
"Shire's commitment to growing its Regenerative Medicine business in San Diego is important to a region where one-in-10 people remain unemployed," said Congressman Brian Bilbray (CA-50). "This investment will not only provide additional opportunities for rewarding, high-paying jobs, but will ensure that San Diego remains a leader in the development of innovative patient care."
Shire expects to begin construction of the new campus in Sorrento Mesa in 2013, with initial occupancy targeted for 2014.
"We are pleased to enter into this partnership with Advanced BioHealing, which is the culmination of extensive, collaborative efforts by both companies to identify and execute on a real estate solution which will fully support their development and manufacturing needs," said Alan D. Gold, Chairman and Chief Executive Officer of BioMed Realty. "We look forward to working closely with the Advanced BioHealing and Shire teams to develop this future multi-phase campus for the development and commercialization of important regenerative medicine therapies."
The company plans to maintain its current DERMAGRAFT manufacturing facility on North Torrey Pines Road in La Jolla, CA, which currently employs nearly 200 people.
Read more:
Shire's Advanced BioHealing Commits to Developing Regenerative Medicine Campus in San Diego
Family Medicine Center Brings New Primary and Preventive Care Options to West Kendall
MIAMI--(BUSINESS WIRE)--
West Kendall Baptist Hospitals new Family Medicine Center is now open, providing area residents with high-quality primary and preventive care. West Kendall residents can now turn to the Baptist Health Medical Group Family Medicine Center at West Kendall Baptist Hospital for all routine care needs, such as physical examinations (including school physicals), flu and allergy shots, non-emergency illnesses and injuries and chronic disease management.
The opening of the Family Medicine Center is the next step toward our goal of creating a comprehensive healthcare community here, said Javier Hernndez-Lichtl, CEO of West Kendall Baptist Hospital. Residents already turn to us for inpatient care, surgeries, emergencies and childbirth. Now we can serve their day-to-day care needs, as well, for the entire family.
The Family Medicine Center, conveniently located on the first floor of the hospitals Medical Arts Building, is designed to promote a vision of providing leading practices in education and compassionate care in a high-tech and high-touch environment. The state-of-the-art facility includes six private exam rooms, on-site laboratory, group meeting room, teleconference center and wireless computer tablets for patient registration. The Center will serve patients of all ages, including pediatric and geriatric patients.
"West Kendall residents are welcome to call and arrange a tour, said Agueda Hernndez, M.D., medical director of the Family Medicine Center. Our staff will be here to welcome you and assist in setting up your new care relationships and transferring records.
Staff physicians include Dr. Hernndez and Manuel Torres, M.D. They have admitting privileges at West Kendall Baptist Hospital as well as other facilities in the Baptist Health South Florida network. The Family Medicine Center will also function as the primary training ground for the West Kendall Baptist Hospital Family Medicine Residency Program, in affiliation with Florida International Universitys Herbert Wertheim College of Medicine, which will launch in the summer of 2013.
The Family Medicine Center is located in the Medical Arts Building adjacent to West Kendall Baptist Hospital, 15955 SW 96 Street. Regular office hours are 9 a.m. to 5 p.m., Monday through Friday. Most major forms of health insurance are accepted. For more information or to make an appointment, call 786-467-3140.
Since opening its doors in April 2011, West Kendall Baptist Hospital personnel have treated more than 30,000 patients in its emergency room, and welcomed more than 200 babies at the Beautiful Beginnings Family Birthing Suites. Other notable awards include becoming the first acute-care hospital in Florida to earn LEED Gold certification for its environmentally conscious facilities and practices, and ranking as the #1 Most Beautiful Hospital in Florida and fourth most beautiful nationwide.
About West Kendall Baptist Hospital
The newest member of the not-for-profit Baptist Health South Florida family, West Kendall Baptist Hospital is a LEED Gold-certified, patient- and family-centered facility serving one of South Floridas most vibrant, youthful and fast-growing communities. Beginning in 2013, the hospital will be home to an accredited family practice residency program through its affiliation with Florida International Universitys Herbert Wertheim College of Medicine. To learn more, visit WestKendallBaptistHospital.com.
Follow this link:
Family Medicine Center Brings New Primary and Preventive Care Options to West Kendall
MindChild Medical, Inc., Announces Results of National Fetal Monitoring Market Survey
NORTH ANDOVER, Mass.--(BUSINESS WIRE)--
MindChild Medical, Inc., today announced results of a recently sponsored national survey of hospital administrators and obstetricians (NSFM3) focused on trends in fetal monitoring. Recent fetal monitoring literature suggests that of the 4.3 million US live births recorded in 20074, 1.4 million, or over 30%5, occurred where the mother had a BMI (Body Mass Index) exceeding 30kg/m2 considered the effective limit for existing non-invasive fetal monitoring technology6.
Key findings of the NSFM Survey included:
Michael G. Ross, MD, MPH7, Professor, Department of Obstetrics and Gynecology at the Geffen School of Medicine at UCLA commented, Noninvasive FHR monitoring may result in inadvertent monitoring of maternal heart rate, which can be mistaken for fetal heart rate, particularly in obese patients. The increase in maternal BMI seen nationally over the recent past is a troubling trend that has significant negative implications for the accuracy of existing non-invasive FHR monitoring technologies. The use of non-invasive surface electrodes can potentially improve in the monitoring of fetal heart rate and aid in prevention of adverse outcomes associated with mistaken maternal heart rate monitoring.
Previous Announcements
On February 22, 2012, MindChild reported formation of a Clinical Advisory Board for the MERIDIAN Line of Non-Invasive Fetal Heart Rate Monitors
On February 6, 2012, MindChild reported filing of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for the MERIDIAN Line of Non-Invasive Fetal Heart Rate Monitors
About the MERIDIAN Non-Invasive Fetal Heart Rate Monitor
MERIDIAN is a fetal monitor that non-invasively measures and displays Fetal Heart Rate (FHR). MERIDIAN acquires and displays the FHR tracing from abdominal surface electrodes that detect the fetal ECG signal (fECG). MERIDIAN may also be used to measure and display FHR using a Fetal Scalp Electrode (FSE). MERIDIAN is designed for women who are at term (> 36 completed weeks), in labor, with singleton pregnancies, using surface electrodes on the maternal abdomen. MERIDIAN is intended for use by healthcare professionals in a clinical setting.
About the Fetal Heart Monitoring Market
See the original post:
MindChild Medical, Inc., Announces Results of National Fetal Monitoring Market Survey